News & Events about West Pharmaceutical Services Inc.
West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) CEO Eric Mark Green sold 44,000 shares of the companys stock in a transaction on Monday, December 5th. The stock was sold at an average price of $238.99, for a total value of $10,515,560.00. Following the transaction, the chief executive ...
Ticker Report
3 months ago
Commonwealth Equity Services LLC trimmed its position in West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 1.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,471 shares of the medical instruments suppliers ...
Ticker Report
4 months ago
Sawtooth Solutions LLC lifted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 16.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 963 shares of the medical ...
Veriti Management LLC grew its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 2.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,217 shares of the medical ...
Ticker Report
4 months ago
Arkadios Wealth Advisors lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST Get Rating) by 35.3% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,285 shares of the medical instruments suppliers ...